Bristol

bristol-myers’-$800m-adc-hits-primary-survival-endpoints-in-phase-3-breast-cancer-trial

Biotechnology Bristol Uncategorized

Bristol Myers’ $800M ADC hits primary survival endpoints in phase 3 breast cancer trial

Feb 26, 2026

A Chinese phase 3 trial of Bristol Myers Squibb’s antibody-drug conjugate has hit its dual primary...

bristol-myers-and-evinova-pen-global-development-partnership

Bristol Research Uncategorized

Bristol Myers and Evinova pen global development partnership

Feb 9, 2026

Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big...

bristol-myers-squibb-taps-microsoft’s-ai-detection-network-for-speedy-lung-cancer-diagnosis

Bristol Medical Technology Uncategorized

Bristol Myers Squibb taps Microsoft’s AI detection network for speedy lung cancer diagnosis

Jan 20, 2026

Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer...